HLA-A
Basic information
Region (hg38): 6:29941260-29949572
Links
Phenotypes
GenCC
Source:
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Drug-induced toxicity, susceptibility to | AD | Pharmacogenomic | Susceptibility to adverse reactions (including Stevens-Johnson syndrome), may have pharmacogenomic relevance related to a number of medications, including allopurinol, carbamazepine; HIV disease, progression in | General | 15743917; 17258541; 21149285; 21428768; 21428769 |
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the HLA-A gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 0 | |||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 1 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | 2 | |||
non coding | 0 | |||||
Total | 0 | 1 | 0 | 1 | 0 |
Variants in HLA-A
This is a list of pathogenic ClinVar variants found in the HLA-A region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
6-29941373-A-G | Uncertain significance (-) | |||
6-29942594-C-T | - | no classification for the single variant (-) | ||
6-29942772-G-A | EBV-positive nodal T- and NK-cell lymphoma | Likely benign (-) | ||
6-29942863-C-T | - | no classification for the single variant (-) | ||
6-29942944-G-A | Likely benign (Jan 01, 2024) | |||
6-29942965-G-C | - | no classification for the single variant (-) | ||
6-29942982-T-A | - | no classification for the single variant (-) | ||
6-29942984-G-A | - | no classification for the single variant (-) | ||
6-29942985-A-G | - | no classification for the single variant (-) | ||
6-29942990-G-C | - | no classification for the single variant (-) | ||
6-29942994-C-T | - | no classification for the single variant (-) | ||
6-29942996-C-G | - | no classification for the single variant (-) | ||
6-29942997-T-C | - | no classification for the single variant (-) | ||
6-29943000-G-T | - | no classification for the single variant (-) | ||
6-29943002-G-C | - | no classification for the single variant (-) | ||
6-29943261-G-A | Likely benign (Jul 01, 2022) | |||
6-29943287-A-G | - | no classification for the single variant (-) | ||
6-29943307-G-A | Abnormality of neuronal migration | Benign (Oct 31, 2014) | ||
6-29943309-T-C | - | no classification for the single variant (-) | ||
6-29943321-T-C | - | no classification for the single variant (-) | ||
6-29943337-G-A | - | no classification for the single variant (-) | ||
6-29943372-C-T | - | no classification for the single variant (-) | ||
6-29943426-A-C | - | no classification for the single variant (-) | ||
6-29943448-A-G | - | no classification for the single variant (-) | ||
6-29943451-A-T | - | no classification for the single variant (-) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
HLA-A | protein_coding | protein_coding | ENST00000396634 | 8 | 4625 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00133 | 0.992 | 80841 | 5909 | 38993 | 125743 | 0.198 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.0962 | 214 | 210 | 1.02 | 0.0000110 | 2195 |
Missense in Polyphen | 67 | 94.231 | 0.71102 | 1059 | ||
Synonymous | 0.618 | 79 | 86.3 | 0.915 | 0.00000483 | 674 |
Loss of Function | 2.36 | 8 | 19.1 | 0.418 | 8.27e-7 | 199 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.466 | 0.393 |
Ashkenazi Jewish | 0.223 | 0.194 |
East Asian | 0.510 | 0.444 |
Finnish | 0.158 | 0.132 |
European (Non-Finnish) | 0.193 | 0.154 |
Middle Eastern | 0.510 | 0.444 |
South Asian | 0.342 | 0.307 |
Other | 0.240 | 0.202 |
dbNSFP
Source:
- Function
- FUNCTION: Involved in the presentation of foreign antigens to the immune system.;
- Pathway
- Antigen processing and presentation - Homo sapiens (human);Cell adhesion molecules (CAMs) - Homo sapiens (human);Type I diabetes mellitus - Homo sapiens (human);Kaposi,s sarcoma-associated herpesvirus infection - Homo sapiens (human);Allograft rejection - Homo sapiens (human);Graft-versus-host disease - Homo sapiens (human);Viral myocarditis - Homo sapiens (human);Endocytosis - Homo sapiens (human);Autoimmune thyroid disease - Homo sapiens (human);Phagosome - Homo sapiens (human);HTLV-I infection - Homo sapiens (human);Natural killer cell mediated cytotoxicity - Homo sapiens (human);Viral carcinogenesis - Homo sapiens (human);Cellular senescence - Homo sapiens (human);Epstein-Barr virus infection - Homo sapiens (human);Human papillomavirus infection - Homo sapiens (human);Herpes simplex infection - Homo sapiens (human);Proteasome Degradation;Allograft Rejection;Neutrophil degranulation;Disease;ras-independent pathway in nk cell-mediated cytotoxicity;antigen processing and presentation;Cytokine Signaling in Immune system;Host Interactions of HIV factors;HIV Infection;Post-translational protein modification;Metabolism of proteins;Infectious disease;Innate Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Adaptive Immune System;Endosomal/Vacuolar pathway;Antigen processing-Cross presentation;Class I MHC mediated antigen processing & presentation;Nef mediated downregulation of MHC class I complex cell surface expression;Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters;The role of Nef in HIV-1 replication and disease pathogenesis;Interferon gamma signaling;Protein ubiquitination;Interferon alpha/beta signaling;Antigen Presentation: Folding, assembly and peptide loading of class I MHC;Downstream signaling in naïve CD8+ T cells;Interferon Signaling;AP-1 transcription factor network;TCR signaling in naïve CD8+ T cells;E3 ubiquitin ligases ubiquitinate target proteins;IL12-mediated signaling events
(Consensus)
Intolerance Scores
- loftool
- 0.944
- rvis_EVS
- 8.93
- rvis_percentile_EVS
- 99.96
Haploinsufficiency Scores
- pHI
- 0.191
- hipred
- N
- hipred_score
- 0.466
- ghis
- 0.527
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- essential_gene_gene_trap
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.657
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | High | High | High |
Primary Immunodeficiency | High | High | High |
Cancer | High | High | High |
Mouse Genome Informatics
- Gene name
- H2-Q7
- Phenotype
Gene ontology
- Biological process
- positive regulation of T cell mediated cytotoxicity;antigen processing and presentation of peptide antigen via MHC class I;antigen processing and presentation of endogenous peptide antigen via MHC class Ib;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent;antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent;immune response;regulation of immune response;interferon-gamma-mediated signaling pathway;type I interferon signaling pathway
- Cellular component
- Golgi membrane;extracellular space;endoplasmic reticulum;Golgi apparatus;plasma membrane;external side of plasma membrane;cell surface;ER to Golgi transport vesicle membrane;phagocytic vesicle membrane;early endosome membrane;MHC class I protein complex;recycling endosome membrane;integral component of lumenal side of endoplasmic reticulum membrane
- Molecular function
- RNA binding;signaling receptor binding;protein binding;beta-2-microglobulin binding;peptide antigen binding